A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
Slingerland M, Valera S, Waldron E, Mu S, Porro M, Loman N, Sandstrom P, Sharma S, Clive S, Hess D, Gelderblom H. A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function. Cancer Chemother Pharmacol 2014; 74:1089-98.
Sep 25, 2014
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
Sep 25, 2014
Cancer Chemother Pharmacol 2014; 74:1089-98
Slingerland Marije, Valera Sue-Zette, Waldron Edward, Mu Song, Porro Maria G, Loman Niklas, Sandstrom Per, Sharma Sunil, Clive Sally, Hess Dagmar, Gelderblom Hans
more
